Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

504344 (+)-WIN 55,212-2 mesylate - CAS 131543-23-2 - Calbiochem

(+)-WIN 55,212-2 mesylate - CAS 131543-23-2 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: WIN 55,212-2 MESYLATE, WIN55, R(+)-WIN 55,212-2 ,MESYLATE HIGH AFFINIT Y CANNABI, R(+)-WIN 55,212-2 MESYLATE, WIN 55,212-2, (R)-(+)-(2,3; Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1.2.3-de]-1,4-benzoxazin-6-yl)-1-naphthalenylmethanonemesy;, 212-2Mesylate

Primary Target: CB receptors
504344
  
Purchase on Sigma-Aldrich

Přehled

Replacement Information

Tabulka spec. kláve

CAS #Empirical Formula
131543-23-2C₂₇H₂₆N₂O₃ CH₃SO₃H
Description
OverviewA potent agonist for cannabinoid receptors with higher affinity to subtype 2 (CB2, Ki = 3.3 nM) than to subtype 1 (CB1, Ki = 62.3 nM).
Catalogue Number504344
Brand Family Calbiochem®
SynonymsWIN 55,212-2 MESYLATE, WIN55, R(+)-WIN 55,212-2 ,MESYLATE HIGH AFFINIT Y CANNABI, R(+)-WIN 55,212-2 MESYLATE, WIN 55,212-2, (R)-(+)-(2,3; Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1.2.3-de]-1,4-benzoxazin-6-yl)-1-naphthalenylmethanonemesy;, 212-2Mesylate
References
ReferencesPalazzo, E., et al. 2012. Neuroscience. 85, 327.
Ferraro, L., et al. 2001. Cerebral Cortex. 11,728.
Price, T., et al. 2004. Br. J. Pharmacol. 142, 257.
Martellotta, M., et al. 1998. Neuroscience. 85, 327.
Griffin,G., et al. 1998. J. Pharmacol. Exp. Ther. 285, 553.
Product Information
CAS number131543-23-2
FormOff-white solid
Hill FormulaC₂₇H₂₆N₂O₃ CH₃SO₃H
Chemical formulaC₂₇H₂₆N₂O₃ CH₃SO₃H
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetCB receptors
Primary Target K<sub>i</sub>62.3 and 3.3 nM for CB₁ and CB₂ receptors, respecively.
Purity≥98% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Standard Handling
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -30°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
504344 0

Documentation

(+)-WIN 55,212-2 mesylate - CAS 131543-23-2 - Calbiochem MSDS

Title

Safety Data Sheet (SDS) 

References

Přehled odkazů
Palazzo, E., et al. 2012. Neuroscience. 85, 327.
Ferraro, L., et al. 2001. Cerebral Cortex. 11,728.
Price, T., et al. 2004. Br. J. Pharmacol. 142, 257.
Martellotta, M., et al. 1998. Neuroscience. 85, 327.
Griffin,G., et al. 1998. J. Pharmacol. Exp. Ther. 285, 553.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision21-June-2013 JSW
SynonymsWIN 55,212-2 MESYLATE, WIN55, R(+)-WIN 55,212-2 ,MESYLATE HIGH AFFINIT Y CANNABI, R(+)-WIN 55,212-2 MESYLATE, WIN 55,212-2, (R)-(+)-(2,3; Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1.2.3-de]-1,4-benzoxazin-6-yl)-1-naphthalenylmethanonemesy;, 212-2Mesylate
DescriptionA potent agonist for cannabinoid receptors with higher affinity to subtype 2 (CB2, Ki = 3.3 nM) than to subtype 1 (CB1, Ki = 62.3 nM).
FormOff-white solid
CAS number131543-23-2
Chemical formulaC₂₇H₂₆N₂O₃ CH₃SO₃H
Structure formulaStructure formula
Purity≥98% by HPLC
SolubilityDMSO (30 mg/ml)
Storage Protect from light
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -30°C.
Toxicity Standard Handling
ReferencesPalazzo, E., et al. 2012. Neuroscience. 85, 327.
Ferraro, L., et al. 2001. Cerebral Cortex. 11,728.
Price, T., et al. 2004. Br. J. Pharmacol. 142, 257.
Martellotta, M., et al. 1998. Neuroscience. 85, 327.
Griffin,G., et al. 1998. J. Pharmacol. Exp. Ther. 285, 553.